Bone Marrow Transplants Could Treat ALSlabiotech (press release) (blog)Spanish researchers are developing a treatment for amyotrophic lateral sclerosis (ALS) which could stop progressive muscle paralysis using adult stem cells from bone marrow. Researc… Continue reading
The use of immunotherapy to treat metastatic breast cancer – BrinkwireBrinkwire (press release)Breast cancer, in the stage with distant metastases, is an incurable disease with a 5 years survival rate of about 5-10% (1). Immunotherapy has recently impr… Continue reading
R & D MagazineNew CRISPR Technology Targets RNAR & D MagazineA team from the Salk Institute has created a new gene-editing tool that targets RNA and could correct a protein imbalance in the cells of dementia patients, restoring them to healthy levels. … Continue reading
R & D MagazineNew CRISPR Technology Targets RNAR & D MagazineA team from the Salk Institute has created a new gene-editing tool that targets RNA and could correct a protein imbalance in the cells of dementia patients, restoring them to healthy levels. … Continue reading
ALS Drug Target Uncovered Through CRISPR ApproachSpecialty Pharmacy TimesThrough gene editing, researchers may have determined key genetic drivers of amyotrophic lateral sclerosis (ALS), according to a study published by Nature Genetics. These findings… Continue reading
ALS Drug Target Uncovered Through CRISPR ApproachSpecialty Pharmacy TimesThrough gene editing, researchers may have determined key genetic drivers of amyotrophic lateral sclerosis (ALS), according to a study published by Nature Genetics. These findings… Continue reading
NasdaqCancer immunotherapy biotech Unum Therapeutics sets terms for $75 million IPONasdaqUnum Therapeutics, which is developing antibody-coupled T cell immunotherapies for cancers, announced terms for its IPO on Monday. The Cambridge, MA-based company … Continue reading
NasdaqCancer immunotherapy biotech Unum Therapeutics sets terms for $75 million IPONasdaqUnum Therapeutics, which is developing antibody-coupled T cell immunotherapies for cancers, announced terms for its IPO on Monday. The Cambridge, MA-based company … Continue reading